series-c-plus
Stage
1
Investors
About
Cipher Pharmaceuticals develops and acquires specialty pharmaceutical products focused on dermatology, hospital acute care, and specialty medicine, addressing unmet medical needs with a portfolio of commercial and pipeline drugs.
Explore Cipher Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.